3-`HYDROXY-(-4-TRIFLUOROMETHY LPHENYL)-METHYL-7-SPIROCYCLO BUTYL5,6,7,8-TETRAHYDROQUINOLIN-5-OL DERIVATIVES AND THE USE OF THE SAME AS CHOLESTEROL ESTER TRANSFER PROTEIN (CETP) INHIBITORS

Details for Australian Patent Application No. 2002337107 (hide)

Owner BAYER AKTIENGESELLSCHAFT

Inventors GIELEN, Heike; GOLDMANN, Siegfried; KELDENICH, Jorg; PAULSEN, Holger; SCHMECK, Carsten; SIEGEL, Stephan; BISCHOFF, Hilmar; RAABE, Martin; SCHMIDT, Delf; FAESTE, Christiane

Pub. Number AU-A-2002337107

PCT Number PCT/EP02/10444

PCT Pub. Number WO2003/028727

Priority 101 48 436.4 01.10.01 DE

Filing date 18 September 2002

Wipo publication date 14 April 2003

International Classifications

A61K 031/4747 - spiro-condensed

C07D 221/20 Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 101 48 436.4 01.10.01 DE

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002337107

17 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002337108-MOTOR VEHICLE REAR SEAT

2002337106-1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1antagonistic activity